Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

H.I.G. Capital

Investor type Private Equity Firm
Founders Sami Mnaymneh Tony Tamer

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 155
Average round size
info
The average size of a deal this fund participated in
$13M
Portfolio companies 122
Rounds per year 5.34
Lead investments 39
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.21
Exits 48
Key employees 29
Stages of investment
Private Equity

Areas of investment

  • Software
  • Health Care
  • Biotechnology
  • Manufacturing
  • Information Technology
Summary

H.I.G. Capital is the famous VC, which was founded in 1993. The main department of described VC is located in the Miami. The fund was located in North America if to be more exact in United States.

The fund was created by Sami Mnaymneh, Tony Tamer. Besides them, we counted 29 critical employees of this fund in our database.

The important activity for fund was in 2006. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 14 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 7-12 investment rounds annually. The higher amount of exits for fund were in 2015. Comparing to the other companies, this H.I.G. Capital performs on 2 percentage points more the average number of lead investments.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline MX Technologies, Centerfield, Xtera For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Therapeutics, Information Technology.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the H.I.G. Capital, startups are often financed by Sevin Rosen Funds, Cordova Ventures, Ventures West. The meaningful sponsors for the fund in investment in the same round are ATDC, Sevin Rosen Funds, Intersouth Partners. In the next rounds fund is usually obtained by Cordova Ventures, Boston Millennia Partners, Sevin Rosen Funds.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of H.I.G. Capital:
Typical Co-investors
H.I.G. Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after H.I.G. Capital:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ThoughtFocus

Banking
Business Development
Consulting
Consulting Services (B2B)
Finance
Information Technology
IT Consulting and Outsourcing
Media and Information Services (B2B)
Software
02 Nov 2022 Wisconsin, United States

Load One, LLC

Travel
22 Jun 2022 -

Lovett Care

Nursing and Residential Care
21 Mar 2022 Stoke-on-Trent, England, United Kingdom

3Pillar Global

Android
Consulting
iOS
Mobile
Mobile Apps
SaaS
Software
27 Oct 2021 Virginia, United States

Zerigo Health

Biopharma
Biotechnology
Health Care
Health Diagnostics
Medical
Medical Device
Therapeutics
$43M21 Oct 2021 San Diego, California, United States

Clarus Therapeutics

Biotechnology
Life Science
Therapeutics
$25M10 Sep 2021 Illinois, United States

The Bluebird Group

Consulting
Consumer Goods
Internet
Retail
09 Aug 2021 Minneapolis, Minnesota, United States

Suzy

Artificial Intelligence
Business Intelligence
Crowdsourcing
Product Research
SaaS
$50M28 Jul 2021 New York, New York, United States

MISCOwater

Water
Water Purification
26 Jul 2021 Foothill Ranch, California, United States
News
Zerigo Health Raises $43 Million in Series B Funding to Drive Adoption of the Industry’s Only Connected Light Therapy Solution to Treat Chronic Skin Conditions

– Zerigo Health announced a $43m Series B investment led by 7wireVentures, joined by General Catalyst, Dragoneer, Cigna Ventures, Leverage Health Solutions, and Leaps by Bayer.
– The round also included participation by existing investors including SV Health Investors, H.I.G. Capital, and Bluestem Capital.
– This round will allow Zerigo Health to respond to the increasing demand for its innovative connected chronic skin condition solution for the over 40 million Americans living with psoriasis, vitiligo, and eczema.
– Glen Tullman, Managing Partner of 7wireVentures, former Founder and CEO of Livongo, and Chief Executive Officer of Transcarent, will join as Executive Chairman of the company’s Board of Directors.

Augmedics Raises $36M in Series C Funding

– Augmedics is a Chicago, IL-based provider of an augmented reality surgical image guidance solutions.
– Company raised $36m in Series C funding.
– The round was led by H.I.G. Capital, Revival Healthcare Capital, and Almeda Ventures with participation from HCA Healthcare Health Insight Capital, as well as existing investor XR Invest (formally known as AO Invest).
– The new investment will be used to continue commercialization throughout the U.S. and into OUS markets, develop the next generation of products, expand to new indications, and obtain CE certification for sales in Europe.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent H.I.G. Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: